Charles Oyesile, M.D. PhD is a Founder and CEO at PolyCRA based in San Antonio, Texas, United States, North America. As the CEO of NucleoBio, Corp., a biotechnology company that develops novel diagnostics and therapeutics for cancer and infectious diseases, I oversee the strategic vision, business development, and R&D operations. With my dual degrees in medicine and infectious diseases, I bring a unique combination of scientific and clinical knowledge, as well as entrepreneurial and leadership skills, to the organization. I am also the founder and CEO of PolyCRA (formerly TPKR Scientifics), a consulting firm that supports clinical innovations through talent development and employee job readiness. I have more than 22 years of experience in the life science, healthcare, and education industries, with expertise in medical devices, drug development, regulatory affairs, project management, and product life cycle development. I have contributed to multiple patents, publications, and grants, and served as an advisor, board member, and adjunct faculty for various companies, organizations, and institutions. I am passionate about advancing the field of clinical research and fostering a culture of excellence, innovation, and collaboration.
Current Position: Founder and CEO
Company: PolyCRA
Location: San Antonio, Texas, United States, North America
Social: Professional profiles available
Network: Extensive professional connections